期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS LetPub Score 6.4
50 ratings
Rate
Reputation 7.6 Influence 5.0 Speed 9.1 | ||||||||||||||||||||
期刊簡稱 | AM J CLIN ONCOL-CANC | ||||||||||||||||||||
ISSN | 0277-3732 | ||||||||||||||||||||
E-ISSN | 1537-453X | ||||||||||||||||||||
h-index | 72 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://journals.lww.com/amjclinicaloncology/pages/default.aspx | ||||||||||||||||||||
在線稿件提交 | |||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Lippincott Williams and Wilkins Ltd. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 1982 | ||||||||||||||||||||
每年文章數 | 77每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 9.84% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0277-3732%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 下一頁 末頁 (頁 | |
[AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS] 的評論 | 撰寫評論 |
作者: 深渊伟诚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-26 18:01:38 評論於 How long did it take for your work to be indexed in Web of Science in the end?(0) 讚! | 深渊伟诚 |
作者: 华清安宜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-22 12:34:41 評論於 Me too, how long have you been in this state?(0) 讚! | 华清安宜 |
作者: 华清安宜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-14 15:47:28 評論於 Review Speed: 1.0 | Submission Hit Rate: 25.0 Experience Sharing: I don't know why his website always can't be accessed, it's inexplicably server timeout. Anyone else encountered the same problem?(0) 讚! | 华清安宜 |
作者: 德义桑 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-17 12:13:28 評論於 How are you doing now?(0) 讚! | 德义桑 |
作者: Miranda 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-28 13:17:19 評論於 How are you doing, bro? Has the feedback come back yet?(0) 讚! | Miranda |
作者: 怀梦酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-29 22:32:40 評論於 Have you submitted the final draft? I'm thinking about submitting a meta-analysis. Could you share your experience?(0) 讚! | 怀梦酱大魔王 |
作者: 伊恩洛克 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-15 23:06:05 評論於 It's not like that anymore(0) 讚! | 伊恩洛克 |
作者: 莫迪丝蒂济慈 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-17 10:22:40 評論於 Research Focus: Tumor Clinical Experience Sharing: After a week, it will become "with editor", hoping not to be rejected(0) 讚! | 莫迪丝蒂济慈 |
作者: 云来南芙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-21 21:05:35 評論於 Oh no, my knowledge is quite basic(0) 讚! | 云来南芙 |
作者: 云来南芙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-01-21 20:10:54 評論於 Can't you just start with the basics? Don't you accept beginners?(0) 讚! | 云来南芙 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:24:15 評論於 There are many methods for writing an introduction, but the general rule is that you only need to describe the problem(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:42:49 評論於 Introduction is focused on presenting the problems to be solved and the innovativeness or value of one's research. The Discussion section needs to thoroughly compare and analyze the strengths and weaknesses of one's research results with those of previous studies. The emphasis of the two sections is different(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 16:55:17 評論於 Introduction and discussion on how to write without repeating?(0) 讚! | 破戒阳平 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:41:06 評論於 What are the differences between writing an introduction and a discussion?(0) 讚! | 陶宜三岁啦 |
作者: 伊万索默菲尔德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-20 22:40:12 評論於 Have you submitted the application? Are individual cases being accepted? I couldn't find any related information on the official website(0) 讚! | 伊万索默菲尔德 |
作者: 水桥半梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-13 19:57:59 評論於 One of the recommended transfers is the Academy of Medical Sciences, and another one is not suitable(0) 讚! | 水桥半梅 |
作者: 佛光葛菲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-07 10:55:44 評論於 What are the consequences of switching?(0) 讚! | 佛光葛菲 |
作者: 江南金莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-11-06 09:39:20 評論於 Please translate the following paragraph into English and Japanese, and title them as ":" and ":"(0) 讚! | 江南金莲 |
作者: Poppy Ferdinand 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-26 14:50:19 評論於 How did it turn out in the end?(0) 讚! | Poppy Ferdinand |
作者: 水桥半梅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-17 10:24:28 評論於 Focused research area: tumor; SEER experience sharing: Successfully submitted a bioinformatics paper for a senior colleague on October 4th, but got rejected on October 8th. Recommended two other journals for resubmission(0) 讚! | 水桥半梅 |
作者: 血天叶农 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-09-12 19:39:36 評論於 Did you receive it later on? Can you share the time of each phase?(0) 讚! | 血天叶农 |
作者: 黑山醉巧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-06 08:04:21 評論於 Did you submit it finally? I want to submit a meta-analysis. Can you share your experience?(0) 讚! | 黑山醉巧 |
作者: 香风语梦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-07-05 23:58:47 評論於 My paper was submitted to the journal, and then nothing happened(0) 讚! | 香风语梦 |
作者: 月河德义 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-01-06 13:03:12 評論於 May I ask what happened to your article later?(0) 讚! | 月河德义 |
作者: 通幽以珊 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-11-22 20:51:03 評論於 Do you have the reference format for the endnote of this magazine?(0) 讚! | 通幽以珊 |
首頁 上一頁 1 2 3 下一頁 末頁 (頁 |
Contact us